Post-transplant native pneumonectomy for interstitial fibrosis and small cell lung cancer

Ramon T. Li, Sanam Zahedi, Judy Trieu, Alfred S. Lea, William J. Calhoun, Alexander G. Duarte, Jianping Zhao, Ikenna C. Okereke

Research output: Contribution to journalArticlepeer-review


Lung transplantation is a definitive treatment for select patients with end-stage pulmonary disease. Following transplantation, the reported rate of lung cancer is between 1-9% and is associated with a variety of risk factors, including smoking history and chronic immunosuppression. The majority of posttransplant lung cancer reported in the literature is histologically classified as non-small cell lung carcinoma (NSCLC). We report a unique case of early stage small cell lung carcinoma (SCLC) identified in the native lung following single lung transplantation.

Original languageEnglish (US)
Pages (from-to)E1096-E1099
JournalJournal of Thoracic Disease
Issue number12
StatePublished - Dec 1 2017


  • Lung transplant
  • Pneumonectomy
  • Small cell lung carcinoma (SCLC)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Post-transplant native pneumonectomy for interstitial fibrosis and small cell lung cancer'. Together they form a unique fingerprint.

Cite this